ProQR Therapeutics (PRQR) Return on Sales (2021 - 2025)
Historic Return on Sales for ProQR Therapeutics (PRQR) over the last 5 years, with Q3 2025 value amounting to 3.92%.
- ProQR Therapeutics' Return on Sales fell 16500.0% to 3.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.89%, marking a year-over-year decrease of 13900.0%. This contributed to the annual value of 1.47% for FY2024, which is 27900.0% up from last year.
- Latest data reveals that ProQR Therapeutics reported Return on Sales of 3.92% as of Q3 2025, which was down 16500.0% from 3.21% recorded in Q2 2025.
- In the past 5 years, ProQR Therapeutics' Return on Sales ranged from a high of 0.57% in Q2 2024 and a low of 85.84% during Q1 2021
- In the last 5 years, ProQR Therapeutics' Return on Sales had a median value of 7.31% in 2023 and averaged 18.35%.
- The largest annual percentage gain for ProQR Therapeutics' Return on Sales in the last 5 years was 707500bps (2022), contrasted with its biggest fall of -76600bps (2022).
- Over the past 5 years, ProQR Therapeutics' Return on Sales (Quarter) stood at 72.5% in 2021, then skyrocketed by 76bps to 17.31% in 2022, then soared by 89bps to 1.91% in 2023, then dropped by -23bps to 2.34% in 2024, then tumbled by -67bps to 3.92% in 2025.
- Its Return on Sales was 3.92% in Q3 2025, compared to 3.21% in Q2 2025 and 2.39% in Q1 2025.